期刊文献+

重组腺辅助病毒载体的制备、纯化及其介导的基因转移 被引量:1

Production and Purification of rAAV and Gene Transfer Introduced by rAAV
下载PDF
导出
摘要 目的 :探讨一种制备、纯化重组腺辅助病毒 (r AAV)载体的有效方法。方法 :以质粒 PDG和含有人 apo AIc DNA的AAV载体共转染 2 93T细胞 ,继以 Iodixanol密度梯度离心结合肝素亲和层析法分离、纯化 ,斑点杂交鉴定 r AAV病毒颗粒数 ;并以含人 apo AIc DNA的 r AAV感染 C2 C12细胞。结果 :r AAV颗粒数为 7× 10 1 0 / ml;r AAV成功介导了人 apo AIc DNA在 C2 C12细胞中的表达并持续了 30天 ,在分化为肌管细胞后仍有此表达能力。结论 :本实验采取的制备、纯化 r AAV的方法简便、高效 ,r AAV成功介导 apo AI基因在肌源性细胞 C2 C12中的表达。 Objective:To investigate an efficient way for production and purification of recombinant adeno associated virus vectors. Methods:The 293T cells was cotransfected with PDG and an AAV plasmid containing human apoAIcDNA to produce infectious rAAV, and it was purified by non ionic iodixanol gradients followed by heparin affinity chromatography. The numbers of rAAV particle were assayed by Dot blot, then C2C12 cells was transduced by these vectors. Results:The particle number of rAAV was 7×10 10 /ml and the rAAV successfully mediated the expression of human apoAIcDNA even after differentiation into myotubes. The expression of human apoAIcDNA in C2C12 cells lasted for 30 days. Conclusion:The methods which was used for production and purification of rAAV is an efficient way and the rAAV vector can successfully mediate apoAI gene transfer to C2C12 myoblasts.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2001年第3期182-185,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省科委应用基础基金资助项目 ( No BJ980 87)
关键词 重组腺辅助病毒 载体制备 载体纯化 基因转移 recombinant adeno associated virus(rAAV) vector production vector purification
  • 相关文献

参考文献3

  • 1Ziying Yan,Proc Natl Acad Sci USA,2000年,97卷,12期,6716页
  • 2姜泊,分子生物学常用实验方法,1996年,98页
  • 3Samulsci R,J Virol,1989年,63卷,3822页

同被引文献12

  • 1Kohei Kanaya, Yoshihiko Tsuchida, Manabu Inobe, et al.Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model [J].Transplantation, 2003,75: 275-278.
  • 2Zongyou Chen, Lina Lu, Juan Li, et al. Prolonged survival of heart allografts tranduced with AAV-CTLA4Ig [J].Microsurgery, 2003,23: 489-493.
  • 3Selvaranga P, Pinku M, Merrin CY, et al. Adenoassociated virus2-mediated gene transfer in vivo:organtropism and expression of transduced sequences in mice [J]. Gene, 1997,190:203-210.
  • 4P Lane, W Gerhard, S Hubele, et al. Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human γ1 [J].Immunology, 1993,80: 56-61.
  • 5Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat [J]. Surgery,1983,93(1 Pt) :64-69.
  • 6Lenschow DJ, Walunas L, Bluestone JA. CD28/B7 system of T cell costimulation [J]. Annu Rev Immunol,1996.14:233.
  • 7Yanagida N, Nomura M, Yamashita K, et al. Tolerance induction by a single donor pretreatment with the adenovirus vector encoding CTLA4Ig gene in rat orthotopic liver transplantation [J]. Transplant Proc,2001,33: 573-574.
  • 8Guillot C, Mathieu P, Coathalem H, et al. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4-Ig expression [J]. J Immunol,2000,164: 5258-5268.
  • 9Richard S Lee, James R Rusche, Michaella E Maloney,et al. CTLA4Ig-induced linked regulation of allogeneic T cell responses[J]. J Immunol,2001,166:1572-1582.
  • 10Bhoompally Reddy, Sanjeev Gupta, Yelena Chuzhin, et al. The effect of CD28/B7 blockade of alloreactive T and B cells after liver cell transplantation [J].Transplantation, 2001, 71: 801-811.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部